Nyxoah SA (EBR:NYXH)
Belgium
· Delayed Price · Currency is EUR 4.280
+0.155 (3.76%)
Last updated: Dec 5, 2025, 3:13 PM CET
Nyxoah Market Cap
Nyxoah has a market cap or net worth of €184.15 million as of December 5, 2025. Its market cap has decreased by -39.26% in one year.
Market Cap
184.15M
Enterprise Value
182.83M
Revenue
5.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
€4.28
Market Cap Chart
Since September 18, 2020, Nyxoah's market cap has decreased from 417.77M to 184.15M, a decrease of -55.92%. That is a compound annual growth rate of -14.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 184.15M | -40.43% |
| Dec 31, 2024 | 309.15M | 153.09% |
| Dec 29, 2023 | 122.15M | -8.05% |
| Dec 30, 2022 | 132.85M | -72.29% |
| Dec 31, 2021 | 479.37M | 37.44% |
| Dec 31, 2020 | 348.77M | -16.52% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 48.48B |
| UCB SA | 45.58B |
| Financière de Tubize | 9.48B |
| Fagron NV | 1.53B |
| Ion Beam Applications | 328.37M |
| Onward Medical | 183.21M |
| Hyloris Pharmaceuticals | 170.24M |
| Sequana Medical NV | 42.65M |